Literature DB >> 32649747

Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019.

Carolina Garcia-Vidal1, Estela Moreno-García1, Marta Hernández-Meneses1, Pedro Puerta-Alcalde1, Mariana Chumbita1, Nicole Garcia-Pouton1, Laura Linares1, Verónica Rico1, Celia Cardozo1, José Antonio Martínez1, Felipe García1, Josep Mensa1, Pedro Castro2, José María Nicolás2, José Muñoz3, David Vidal4, Alex Soriano1.   

Abstract

Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory, co-infection, and thrombotic) that are identifiable by analytics patterns. Personalized treatment decisions decreased early mortality (odds ratio [OR] .144; 95% confidence interval [CI] .03-.686; P = .015). Increasing age (OR 1.06; P = .038) and therapeutic effort limitation (OR 9.684; P < .001) were associated with higher mortality.
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; patterns; personalized therapy; pneumonia

Mesh：

Year:  2022        PMID： 32649747      PMCID： PMC7454444          DOI： 10.1093/cid/ciaa964

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  13 in total

1.  Trends in mortality of hospitalised COVID-19 patients: A single centre observational cohort study from Spain.

Authors:  Carolina Garcia-Vidal; Alberto Cózar-Llistó; Fernanda Meira; Gerard Dueñas; Pedro Puerta-Alcalde; Catia Cilloniz; Nicole Garcia-Pouton; Mariana Chumbita; Celia Cardozo; Marta Hernández; Verónica Rico; Marta Bodro; Laura Morata; Pedro Castro; Alex Almuedo-Riera; Felipe García; Josep Mensa; José Antonio Martínez; Gemma Sanjuan; Antoni Torres; J M Nicolás; Alex Soriano
Journal:  Lancet Reg Health Eur       Date:  2021-01-24

2.  Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain.

Authors:  Alejandro Rodríguez; Manuel Ruiz-Botella; Ignacio Martín-Loeches; María Jimenez Herrera; Jordi Solé-Violan; Josep Gómez; María Bodí; Sandra Trefler; Elisabeth Papiol; Emili Díaz; Borja Suberviola; Montserrat Vallverdu; Eric Mayor-Vázquez; Antonio Albaya Moreno; Alfonso Canabal Berlanga; Miguel Sánchez; María Del Valle Ortíz; Juan Carlos Ballesteros; Lorena Martín Iglesias; Judith Marín-Corral; Esther López Ramos; Virginia Hidalgo Valverde; Loreto Vidaur Vidaur Tello; Susana Sancho Chinesta; Francisco Javier Gonzáles de Molina; Sandra Herrero García; Carmen Carolina Sena Pérez; Juan Carlos Pozo Laderas; Raquel Rodríguez García; Angel Estella; Ricard Ferrer
Journal:  Crit Care       Date:  2021-02-15       Impact factor: 9.097

Review 3.  Personalized therapy: can it tame the COVID-19 monster?

Authors:  Mohd Arish; Farha Naz
Journal:  Per Med       Date:  2021-10-15       Impact factor: 2.512

4.  Blockchain and AI-Based Solutions to Combat Coronavirus (COVID-19)-Like Epidemics: A Survey.

Authors:  Dinh C Nguyen; Ming Ding; Pubudu N Pathirana; Aruna Seneviratne
Journal:  IEEE Access       Date:  2021-06-30       Impact factor: 3.367

5.  Hospitalized patients with breakthrough COVID-19: Clinical features and poor outcome predictors.

Authors:  Oscar Moreno-Perez; Isabel Ribes; Vicente Boix; María Ángeles Martinez-García; Silvia Otero-Rodriguez; Sergio Reus; Rosario Sánchez-Martínez; Jose Manuel Ramos; Pablo Chico-Sánchez; Esperanza Merino
Journal:  Int J Infect Dis       Date:  2022-02-13       Impact factor: 12.074

6.  Bacterial co-infection at hospital admission in patients with COVID-19.

Authors:  Estela Moreno-García; Pedro Puerta-Alcalde; Laura Letona; Fernanda Meira; Gerard Dueñas; Mariana Chumbita; Nicole Garcia-Pouton; Patricia Monzó; Carlos Lopera; Laia Serra; Celia Cardozo; Marta Hernandez-Meneses; Verónica Rico; Marta Bodro; Laura Morata; Mariana Fernandez-Pittol; Ignacio Grafia; Pedro Castro; Josep Mensa; José Antonio Martínez; Gemma Sanjuan; Mª Angeles Marcos; Alex Soriano; Carolina Garcia-Vidal
Journal:  Int J Infect Dis       Date:  2022-03-05       Impact factor: 12.074

7.  Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19.

Authors:  Fernanda Meira; Estela Moreno-García; Laura Linares; Irene Macaya; Adria Tomé; Marta Hernández-Meneses; Laia Albiach; Laura Morata; Laura Letona; Marta Bodro; Alberto Cózar-Llistó; Celia Cardozo; Mariana Chumbita; Cristina Pitart; Juan Ambrosioni; Verónica Rico; Daiana Agüero; Pedro Puerta-Alcalde; Nicole Garcia-Pouton; Francesc Marco; Carolina Garcia-Vidal; Alex Soriano; José Antonio Martínez
Journal:  Infect Dis Ther       Date:  2021-06-11

8.  Preventive Efficacy of Tenofovir/Emtricitabine Against Severe Acute Respiratory Syndrome Coronavirus 2 Among Pre-Exposure Prophylaxis Users.

Authors:  Oskar Ayerdi; Teresa Puerta; Petunia Clavo; Mar Vera; Juan Ballesteros; Manuel Enrique Fuentes; Vicente Estrada; Carmen Rodríguez; Jorge Del Romero
Journal:  Open Forum Infect Dis       Date:  2020-09-25       Impact factor: 3.835

9.  Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography.

Authors:  Jorge González-Zamora; Valentina Bilbao-Malavé; Elsa Gándara; Anna Casablanca-Piñera; Claudia Boquera-Ventosa; Manuel F Landecho; Javier Zarranz-Ventura; Alfredo García-Layana
Journal:  Biomedicines       Date:  2021-03-02

10.  [Mycophenolate as a corticoid saver in a patient with pneumonia organized by COVID-19].

Authors:  M J Esteve Gimeno; C Roig Martí; I Pérez Catalán; N Tornador Gaya; J Usó Blasco
Journal:  Rev Esp Quimioter       Date:  2021-09-29       Impact factor: 1.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.